| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |